Podcast Host Chris Leidli

Rx for Biotech

Business EN ↓ 97 episodes

"Rx for Biotech" is a healthcare education podcast dedicated to helping patients, caregivers, and healthcare professionals understand the rapidly evolving world of advanced therapies - and how patients can access them. From cell therapies and gene therapies to radiopharmaceuticals, immunotherapies, and next-generation treatments for cancer and autoimmune disease, this channel bridges the gap between breakthrough science and real-world patient care. Hosted by Chris Leidli, founder of Genoplex and longtime host of the Rx for Biotech podcast, each episode features conversations with:• Biotech and...

Be sure to visit the podcast's website and support the creator: soundcloud.com

Author

Podcast Host Chris Leidli

Category

Business

Podcast website

soundcloud.com

Latest episode

Nov 10, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

New Therapies for Kidney Disease with XORTX Therapeutics CEO, Allen Davidoff, PhD 29.03.2023

Allen Davidoff, PhD is the Founder and CEO of XORTX Therapeutics, Inc., a drug based biotechnology company primarily focused on orphan disease indications which have aberrant purine metabolism and frequently high serum uric acid imbalance. This podcast episodes looks at novel therapies in development that may extend kidney health.

FDA AMAT for Regenerative Medicine Therapies Workshop Recap 21.03.2023

This podcast episode provides a short recap of the day long workshop hosted by the FDA’s Office of Therapeutic Products (OTP) a new office within CBER. The goal of the workshop was to share knowledge and best practices from experts in the field of advanced manufacturing and analytical technologies (AMAT) for regenerative medicine therapies. Innovative manufacturing technologies and alternative tes...

Don Davis, PhD, MBA on Challenges in Scaling Life Science Companies 27.02.2023

As Life Science companies grow, they become less efficient. In this podcast episode, Dr. Donald Davis explains what scaling challenges are and what companies can do to become more efficient using the process improvement tools of lean six sigma.

Applications of AI and Machine Learning in BioPharma and Healthcare 14.02.2023

Anyone who has experimented with ChatGPT can get a sense of the potential of generative AI. AI powers driverless cars, spots signs of disease on medical images, finds an answer when you ask Alexa a question, and lets you unlock your phone with your face to talk to friends on the iPhone. Those are just a few ways AI already touches our lives, but there are many ways AI is being utilized in the phar...

A Look Ahead to 2023 Biopharma M&A, Venture Financing, Licensing and Partnerships 23.01.2023

In this podcast episode, we recap highlights from JPM Healthcare conference with Chris Dokomajilar from DealForma, Inc., and review 2023 outlook for Biopharma Dealmaking, Financing, and Partnerships. To join live webinar on February 8th, 2023, use this link: https://us02web.zoom.us/j/6097872444

Biopharma Products and Companies to Watch in 2023 12.01.2023

In this podcast episode, Chris provides a short preview of biotechnology and pharmaceutical companies to watch in 2023.

American Society of Hematology Highlights 16.12.2022

This podcast episode covers the highlights from this year’s American Society of Hematology Annual Meeting that took place in New Orleans in early December. There was enormous excitement for novel therapies for blood cancers and for diseases that previously had very high morbidity and mortality and now, because of novel treatment modalities in the field of hematology, like T cell engagers and CAR-T...

Role of oxMIF in Innate and Adaptive Immunity with OncoOne CBO, Brent Meadows 07.12.2022

OncoOne is a biotech company developing novel therapeutics for patients with solid tumors and autoimmune diseases. In this podcast episode, Brent Meadows, Chief Business Officer and US General Manager, discusses the role of oxMIF in innate and adaptive immunity and outlines the company's development approach and plan for entering the clinic.

How to Improve Customer Engagement in 2023 21.11.2022

In this podcast episode, our guest, Karoline Eastman, SVP of Customer Experience and Strategy Lead at Pixacore, discusses new digital trends for pharma in 2023 and how to improve HCP and patient customer engagement.

Next Generation Non-Viral Gene Therapies with Cove Therapeutics CEO, Niren Shah 07.11.2022

Our guest in this episode is Cove Therapeutics CEO, Niren Shah, who discusses the pitfalls of current viral vector based gene therapies and shares how Cove's next generation non-viral gene delivery platform overcomes many of the challenges of viral vectors.

Meeting on the Mesa Roundtable Part 2: Applying "A-Cell" Concepts when Developing Cell Therapies 27.10.2022

There are many hurdles to streamlined, cost-effective manufacturing of cell and gene therapy products. To help address this, the Alliance for Regenerative Medicine published A-Cell, a case-based guidebook to help drug developers incorporate Quality by Design (QbD) principles into cell-based therapy CMC programs. A-Cell builds on previous QbD efforts that were applied to the manufacturing of monocl...

Meeting on the Mesa Roundtable Part 1: 'A-Cell' Principles of Quality by Design 20.10.2022

There are many hurdles to streamlined, cost-effective manufacturing of cell and gene therapy products. To help address this, the Alliance for Regenerative Medicine published A-Cell, a case-based guidebook to help drug developers incorporate Quality by Design (QbD) principles into cell-based therapy CMC programs. A-Cell builds on previous QbD efforts that were applied to the manufacturing of monocl...

IRA Impact on Biopharma Drug Development 07.10.2022

The Inflation Reduction Act was signed into law in August 2022 and is one of the most significant pieces of healthcare reform since the Affordable Care Act. In this episode, learn more about how the new policy will impact R&D portfolio decision making and new product development strategies.

OTAT Townhall Insights for Developers of Gene Therapies 29.09.2022

The FDA’s Office of Tissues and Advanced Therapies hosted their first virtual town hall to answer industry questions related to gene therapy chemistry, manufacturing, and controls. In this episode, we unpack what happened at the town hall and provide a brief overview of the key insights and guidance from the agency for those developing gene therapies.

Insights into the Cell and Gene Therapy Landscape 22.09.2022

Twice a year, the Alliance for Regenerative Medicine (ARM) surveys the cell and gene therapy landscape to advance the field and provide an update to their members, stakeholders, and the public. In this podcast, Stephen Majors, Senior Director of Public Affairs, reviews key insights from ARM's updated cell and gene therapy sector report for the first half of 2022. ARM is the leading international a...

Medical Communications after the Pandemic 15.09.2022

In this episode, Jan Hannon and Lisa Hefner from BluPrint Oncology dig deeper into scientific and medical communications and how health care provider education has evolved in the post-COVID pandemic era.

Best Practices in Market Access, Trade and Distribution 08.09.2022

In this episode, Paul Callahan, President and Founder of CDT Pharma Strategies discusses market access, trade and distribution best practices for novel therapeutics.

Chandra Ramanathan, PhD on How to Create Value through Innovation Ecosystems 02.06.2022

In this episode, Dr. Ramanathan discusses best practices in Pharmaceutical, Biotechnology, and Academic partnerships, alliance management, and innovation.

Chris Dokomajilar on Trends in Life Science Investing, M&A and Partnering 23.05.2022

The biopharma ecosystem is devoting significant resources to develop novel cell and gene therapies to treat cancer. In this episode of "Rx for Biotech", Chris Dokomajilar discusses trends in Biotechnology investment, licensing and partnering landscape and provides an outlook on what to expect for the remainder of 2022.

CRISPR and Gene Editing for Human Disease 20.06.2020

Our guest in this episode is Dr. Andrew Garst. We discuss the technology behind powerful new genome editing tools that are driving new therapies to treat genomic and inherited human diseases.

The Future of Cell and Gene Therapies 19.05.2020

During this episode, we explore the key opportunities and challenges with the future commercialization of innovative personalized therapies with our guest, Michael Amoroso, a leader in the cell and gene therapy industry.

Regulatory Challenges in Biotech 01.05.2020

In this episode, Dr. Katie Graham reviews FDA regulatory review process for innovative new biotechnology and pharmaceutical products. Dr. Graham shares best practices in helping emerging biotechnology companies accelerate their organizational launch readiness.

Listen to the Rx for Biotech podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.